{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:57:00Z","timestamp":1793775420235,"version":"4.6.1"},"reference-count":114,"publisher":"Informa UK Limited","issue":"18","funder":[{"DOI":"10.13039\/100011404","name":"Indivior","doi-asserted-by":"publisher","award":["Expert meeting attendance"],"award-info":[{"award-number":["Expert meeting attendance"]}],"id":[{"id":"10.13039\/100011404","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011404","name":"Indivior","doi-asserted-by":"publisher","award":["no influence on content"],"award-info":[{"award-number":["no influence on content"]}],"id":[{"id":"10.13039\/100011404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2017,12,12]]},"DOI":"10.1080\/14656566.2017.1409722","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T03:38:12Z","timestamp":1511926692000},"page":"1987-1999","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":129,"title":["Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus"],"prefix":"10.1080","volume":"18","author":[{"given":"Maurice","family":"Dematteis","sequence":"first","affiliation":[{"name":"Department of Addiction Medicine, Grenoble Alpes University Hospital, Grenoble, France"},{"name":"Faculty of Medicine, Grenoble Alpes University, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Auriacombe","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Bordeaux, Bordeaux, France"},{"name":"Addiction Psychiatry Team, SANPsy CNRS USR, Bordeaux, France"},{"name":"P\u00f4le Addictologie, CH Ch. Perrens and CHU Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"D\u2019Agnone","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Human Sciences, Institute of Brain Behaviour and Mental Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Somaini","sequence":"additional","affiliation":[{"name":"Addiction Treatment Centre, Biella, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9stor","family":"Szerman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Hospital Universitario Gregorio Mara\u00f1on, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Littlewood","sequence":"additional","affiliation":[{"name":"Applied strategic, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh","family":"Alam","sequence":"additional","affiliation":[{"name":"Divisional Medical Director, Central & North West London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Alho","sequence":"additional","affiliation":[{"name":"Abdominal Center, University Hospital and University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Benyamina","sequence":"additional","affiliation":[{"name":"Centre d\u2019Enseignement, de Recherche et de Traitement des Addictions, AP-HP, Paris-Sud University Hospital Group, Paul Brousse site, Paris-Sud University, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Bobes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oviedo-CIBERSAM, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Daulouede","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Bordeaux, Bordeaux, France"},{"name":"Addiction Psychiatry Team, SANPsy CNRS USR, Bordeaux, France"},{"name":"Centre d\u05f3Addictologie, BIZIA and CH Bayonne, Bayonne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Leonardi","sequence":"additional","affiliation":[{"name":"Drug Addiction Department, Local Public Health ASL Rome 2, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icro","family":"Maremmani","sequence":"additional","affiliation":[{"name":"Santa Chiara University Hospital, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Torrens","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Legal Medicine, Universidad Autonoma de Barcelona, Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institut), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Walcher","sequence":"additional","affiliation":[{"name":"CONCEPT, Addiction Medicine, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soyka","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Ludwig Maximilian University, Munich, Germany"},{"name":"Medical Park Ciemseeblick, Bernau-Felden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,12,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12060782"},{"key":"CIT0003","first-page":"500","volume-title":"The Routle","author":"Auriacombe M","year":"2017","edition":"1"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.12.024"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3917\/lav.reyna.2016.01.0078","volume-title":"Trait\u00e9 d\u2019addictologie","author":"Auriacombe M","year":"2016"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)76462-X"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2012.00327.x"},{"key":"CIT0009","volume-title":"Methadone and buprenorphine: clinical practice guideline for opioid use disorder","author":"College of Physicians and Surgeons of British Columbia","year":"2016"},{"key":"CIT0010","volume-title":"Saskatchewan methadone guidelines and standards for the treatment of opioid addiction\/dependence","author":"College of Physicians and Surgeons of Saskatchewan","year":"2015"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.642758"},{"key":"CIT0012","unstructured":"Nice TA 114 Methadone and buprenorphine for the management of opioid dependence. 2007; Available from: https:\/\/www.nice.org.uk\/guidance\/ta114\/resources\/methadone-and-buprenorphine-for-the-management-of-opioid-dependence-82598072878789"},{"key":"CIT0013","volume-title":"How can opioid substitution therapy (and drug treatment and recovery systems) be optimised to maximise recovery outcomes for service users?","author":"Advisory Council on the Misuse of Drugs (ACMD)","year":"2015"},{"key":"CIT0014","volume-title":"Drug misuse and dependence. Drug misuse and dependence: UK guidelines on clinical management","author":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group","year":"2017"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16070792"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000193"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/add.13644"},{"key":"CIT0018","volume-title":"New Zealand practice guidelines for opioid substitution treatment","author":"Ministry of Health","year":"2014"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004147.pub4"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.06.024"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.11.022"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health. 2013;28:388\u2013406.","DOI":"10.1080\/19371918.2013.774673"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.10.004"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2012.663296"},{"key":"CIT0025","unstructured":"SAMHSA. Chapter 2. History of medication-assisted treatment for opioid addiction. In: medication-assisted treatment for opioid addiction in opioid treatment programs [Internet]. Rockville; 2005. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64157\/"},{"key":"CIT0026","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. EMCDDA | legal frameworks of opioid substitution treatment [Internet]. 2008 [cited 2017 Nov 8]. Available from: http:\/\/www.emcdda.europa.eu\/html.cfm\/index41823EN.html"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1177\/070674370605101003"},{"key":"CIT0028","unstructured":"EMCDDA. Annual report on the state of the drugs problem in the European Union. Chapter 4 Selected issue: Substitution treatment [Internet]. 2000. Available from: http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_37235_EN_sel00_1en.pdf"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0046-2"},{"key":"CIT0030","unstructured":"Medicines and Healthcare Regulatory Agency. Summary of product characterstics - Subutex 0.4mg sublingual tablets [Internet]. London; 1998. Available from: http:\/\/www.mhra.gov.uk\/home\/groups\/spcpil\/documents\/spcpil\/con1507872154598.pdf"},{"key":"CIT0031","unstructured":"Committee for Medicinal Products for Human Use (EMA). Assessment report - Suboxone [Internet]. Vol. EMA\/774165. London; 2015. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000697\/WC500198036.pdf"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2014.909377"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1159\/000432395"},{"key":"CIT0034","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Health and social responses to drug problems [Internet]. Luxembourg; 2017. Available from: http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/6343\/TI_PUBPDF_TD0117699ENN_PDFWEB_20171009153649.pdf"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20457"},{"key":"CIT0036","unstructured":"EMCDDA. Annual report 2010: the state of the drugs problem in Europe [Internet]. Luxembourg; 2010. Available from: http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/926\/EMCDDA_AR2010_EN_242720.pdf"},{"key":"CIT0037","unstructured":"World Health Organization. How to improve opioid substitution therapy implementation [Internet]. Copenhagen; 2014. Available from: http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0015\/241341\/How-to-improve-Opioid-Substitution-Therapy-implementation.pdf?ua=1:"},{"key":"CIT0038","volume-title":"National guidelines for medication-assisted treatment of opioid dependence","author":"Gowing L","year":"2014"},{"key":"CIT0039","unstructured":"Vancouver Coastal Health & Providence, Health Care Opioid Use Disorder. A guideline for the clinical management of opioid addiction [Internet]. 2015. Available from: http:\/\/www.drugabuse.gov\/publications\/principles-drug-addiction-treatment-research-based-guide-third-edition\/evidence-based-approaches-to-drug-addiction-treatment\/pharmacotherapies"},{"key":"CIT0040","volume-title":"Policy of the department for the treatment of substance abuse: treatment of opioid addiction through psychosocial therapy and maintenance treatment (agonists and partial agonists such as: methadone, buprenorphine\/buprenorphine\/naloxone)","author":"Departement for the Treatment of Substance Abuse","year":"2017"},{"key":"CIT0041","volume-title":"National guidelines for care and support in cases of misuse and addiction","author":"The Swedish National Board of Health and Welfare (Support for governance and management)","year":"2016"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000166"},{"key":"CIT0043","unstructured":"Waller R. Medication Assisted Treatment (MAT) guidelines for opioid use disorders [Internet]. Michigan; 2014. Available from: http:\/\/www.michigan.gov\/documents\/mdhhs\/MAT_Guidelines_for_Opioid_Use_Disorders_524339_7.pdf"},{"key":"CIT0044","unstructured":"WHO. Guidelines for the identification and management of substance use and substance use disorders in pregnancy [Internet]. 2014. Available from: www.who.int\/substance_abuse"},{"key":"CIT0045","author":"College of Psychiatrists in Ireland","year":"2016","journal-title":"Heal Serv Exec [Internet]"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1097\/01.ADM.0000435321.39251.d7"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030080"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12051"},{"key":"CIT0050","volume-title":"Main DRUID results to be communicated to different target groups","author":"Meesmann U","year":"2011"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1999.10471730"},{"issue":"2","key":"CIT0052","first-page":"7","volume":"1","author":"Maremmani I","year":"1999","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2014.12154.x"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/0899-3289(92)90024-R"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.11.001"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06298.x"},{"issue":"5","key":"CIT0057","first-page":"404","volume":"67","author":"Leavitt SB","year":"2000","journal-title":"Mt Sinai J Med [Internet]"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01207-9"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1300\/J069v19n02_03"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a39113"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P759"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12317"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1111\/add.12440"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1159\/000368572"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009879.pub2"},{"key":"CIT0066","volume":"2015210239","author":"Walton G","year":"2015","journal-title":"BMJ Case Rep [Internet]"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544070-00001"},{"key":"CIT0068","unstructured":"Methadone Treatment and Services Advisory Committee. Methadone treatment and services advisory committee final report. Ontario: Ministry of Health and Long-Term Care. Methadone Treatment and Services Advisory Committee; Jun\u00a02016. [cited 27 Nov]. Available from: http:\/\/health.gov.on.ca\/en\/public\/programs\/drugs\/ons\/docs\/methadone_advisory_committee_report.pdf."},{"key":"CIT0069","doi-asserted-by":"crossref","unstructured":"Orman JS, Keating GM, Renzelli CM, et al. Buprenorphine\/Naloxone a review of its use in the treatment of opioid dependence. Drugs. 2009;69(5):577\u2013607.","DOI":"10.2165\/00003495-200969050-00006"},{"issue":"1","key":"CIT0070","volume":"3","author":"Soyka M","year":"2014","journal-title":"Adv Pharmacoepidemiol Drug Saf [Internet]"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.09.004"},{"key":"CIT0072","unstructured":"Soyka M, Hillemacher T.\u00a0Commentary on Hser, et al. 2014. To retain or not to retain \u2014 open questions in opioid maintenance therapy. Addiction. 2014;109(1):88\u201389."},{"issue":"1","key":"CIT0073","first-page":"79","volume":"109","author":"Hser Y-I","year":"2014","journal-title":"Natl Inst Heal"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-001-0975-0"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300251"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.07.035"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1209486"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-017-1415-y"},{"issue":"2","key":"CIT0079","first-page":"CD002207","volume":"2","author":"Mattick RP","year":"2014","journal-title":"Cochrane Database Syst Rev [Internet]"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1111\/add.12333"},{"key":"CIT0081","volume-title":"Buprenorphine\/naloxone versus methadone for the treatment of opioid dependence: a review of comparative clinical effectiveness, cost-effectiveness and guidelines","author":"Canadian Agency for Drugs and Technologies in Health","year":"2016"},{"issue":"8","key":"CIT0082","first-page":"871","volume":"15","author":"Curcio F","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.05.004"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1080\/10550880802122646"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1159\/000321465"},{"issue":"1","key":"CIT0086","first-page":"1","volume":"4","author":"Parvaresh N","year":"2012","journal-title":"Addict Heal"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-9877(98)90264-X"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.06.037"},{"issue":"17","key":"CIT0089","volume":"10","author":"Maremmani AGI","year":"2011","journal-title":"Ann Gen Psychiatry [Internet]"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.11.002"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08725"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2012.05.005"},{"key":"CIT0093","unstructured":"National Institute on Drug Abuse (NIDA). National overdose deaths - number of deaths from benzodiazepines. [Internet]. 2017 [cited 2017 Nov 8]. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-016-0065-6"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1159\/000363232"},{"key":"CIT0096","volume-title":"Opioid addiction medications in patients taking benzodiazepines or CNS Depressants : drug safety communication - careful medication management can reduce risks","author":"FDA","year":"2017"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.07.004"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.08.019"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.10.010"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2009.00009.x"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2009.00001.x"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.09.004"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1111\/add.13375"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2009.00005.x"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011117.pub2"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.0001"},{"key":"CIT0107","first-page":"1","author":"Javaher S","year":"2015","journal-title":"J Pain"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04040.x"},{"key":"CIT0109","volume-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"World Health Organization","year":"2009"},{"key":"CIT0110","first-page":"307","volume-title":"Trait\u00e9 d\u2019addictologie","author":"Auriacombe M","year":"2016"},{"key":"CIT0111","unstructured":"Substance abuse and mental health services administration. Medication-assisted treatment for opioid addiction in opioid treatment programs [Internet]. 2014. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64164\/%5Cnhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22514849"},{"key":"CIT0112","unstructured":"National collaborating centre for mental health (UK). Drug misuse: opioid detoxification [Internet]. British Psychological Society. British Psychological Society; 2008. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21452460"},{"issue":"4","key":"CIT0113","first-page":"39","volume":"14","author":"Fischer G","year":"2012","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"4","key":"CIT0114","first-page":"4","volume":"2017","author":"Saulle R","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2017.1409722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:41:54Z","timestamp":1751038914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2017.1409722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,3]]},"references-count":114,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,12,12]]}},"alternative-id":["10.1080\/14656566.2017.1409722"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2017.1409722","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}